• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Ia型糖原贮积病患者的长期预后

The long-term outcome of patients with glycogen storage disease type Ia.

作者信息

Smit G P

机构信息

Department of Paediatrics, University Hospital of the University of Groningen, The Netherlands.

出版信息

Eur J Pediatr. 1993;152 Suppl 1:S52-5. doi: 10.1007/BF02072089.

DOI:10.1007/BF02072089
PMID:8319726
Abstract

Forty-one patients (16 females and 25 males) over 10 years of age from five different European centres were studied retrospectively. Of those patients 19 were below the 3rd percentile for height. Hypoglycaemia was still reported in 6 patients. Hepatomegaly was present in 39 out of 40, while 11 out of 27 reported patients had marked hepatomegaly (> 10 cm below the costal margin in the midclavicular line). Adenomas were detected in 11 out of 39 patients, alpha-1-fetoprotein was reported to be within normal limits in a total of 22 patients of whom 6 had adenomas. Blood cholesterol concentration was elevated in 31 out of 38 patients, in 7 greater than 10.0 mmol/l. Blood triglycerides were elevated in 29 out of 34 patients, in 8 patients greater than 4.0 mmol/l. Blood uric acid concentration was elevated in 19 out of 35 patients, 12 of them being treated with allopurinol. Mental development was reported to be normal in 32 out of 37 patients. Since limited information on treatment was available no significant differences between treatment groups could be detected. In order to evaluate the effect of treatment, 20 patients (10 females and 10 males) of one centre were studied before and after at least 5 years of treatment. This treatment consisted of frequent feedings during the day together with nocturnal gastric drip feeding. Patients were divided into responders (n = 16) and non-responders (n = 4) depending on their (change in) SDS (standard deviation score) for height. Liver adenomas were detected in 3 patients, of which one was a non-responder. Alpha-fetoprotein was normal in all patients.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对来自欧洲五个不同中心的41名10岁以上患者(16名女性和25名男性)进行了回顾性研究。这些患者中,19名身高低于第3百分位。仍有6名患者报告有低血糖。40名患者中有39名出现肝肿大,27名报告患者中有11名有明显肝肿大(锁骨中线肋缘下>10厘米)。39名患者中有11名检测到腺瘤,22名患者的甲胎蛋白报告在正常范围内,其中6名有腺瘤。38名患者中有31名血胆固醇浓度升高,7名大于10.0毫摩尔/升。34名患者中有29名血甘油三酯升高,8名患者大于4.0毫摩尔/升。35名患者中有19名血尿酸浓度升高,其中12名正在接受别嘌呤醇治疗。37名患者中有32名报告智力发育正常。由于治疗信息有限,未检测到治疗组之间的显著差异。为了评估治疗效果,对一个中心的20名患者(10名女性和10名男性)在至少5年的治疗前后进行了研究。这种治疗包括白天频繁喂食和夜间胃滴注喂食。根据身高的SDS(标准差评分)变化,患者分为反应者(n = 16)和无反应者(n = 4)。3名患者检测到肝腺瘤,其中1名是无反应者。所有患者的甲胎蛋白均正常。(摘要截断于250字)

相似文献

1
The long-term outcome of patients with glycogen storage disease type Ia.Ia型糖原贮积病患者的长期预后
Eur J Pediatr. 1993;152 Suppl 1:S52-5. doi: 10.1007/BF02072089.
2
Gastric drip feeding in patients with glycogen storage disease type I: its effects on growth and plasma lipids and apolipoproteins.I型糖原贮积病患者的胃内滴注喂养:对生长及血浆脂质和载脂蛋白的影响
Pediatr Res. 1989 Apr;25(4):327-31. doi: 10.1203/00006450-198904000-00002.
3
Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I).I型糖原贮积病:诊断、管理、临床病程及预后。欧洲I型糖原贮积病研究(ESGSD I)结果
Eur J Pediatr. 2002 Oct;161 Suppl 1:S20-34. doi: 10.1007/s00431-002-0999-4. Epub 2002 Aug 22.
4
Hemorrhage into a hepatic adenoma and type Ia glycogen storage disease: a case report and review of the literature.肝腺瘤出血与Ia型糖原贮积病:一例报告并文献复习
Surgery. 1985 Jan;97(1):117-24.
5
Glycogen storage disease type I. Results of treatment with frequent daytime feeding, combined with nocturnal intragastric feeding and with administration of an alpha-glucosidase inhibitor.
Eur J Pediatr. 1983 Apr;140(2):102-4. doi: 10.1007/BF00441652.
6
Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease.Ia型糖原贮积病患者的肝细胞腺瘤与代谢平衡
Mol Genet Metab. 2008 Apr;93(4):398-402. doi: 10.1016/j.ymgme.2007.10.134. Epub 2008 Feb 20.
7
Hepatocellular carcinoma in glycogen storage disease type Ia: a case series.Ia型糖原贮积病中的肝细胞癌:病例系列
J Inherit Metab Dis. 2005;28(2):153-62. doi: 10.1007/s10545-005-7500-2.
8
Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.婴儿期开始的持续葡萄糖治疗对I型糖原贮积病患者长期临床病程的影响。
J Pediatr Gastroenterol Nutr. 1999 Aug;29(2):136-43. doi: 10.1097/00005176-199908000-00008.
9
Physical growth and development of children with type 1 glycogen-storage disease: comparison of the effects of long-term use of dextrose and uncooked cornstarch.
Am J Clin Nutr. 1990 Dec;52(6):1051-7. doi: 10.1093/ajcn/52.6.1051.
10
Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease.持续夜间胃内喂养用于1型糖原贮积病的治疗
N Engl J Med. 1976 Feb 19;294(8):423-5. doi: 10.1056/NEJM197602192940805.

引用本文的文献

1
Clinical, laboratory and molecular features of glycogen storage disease type 1a and 1b patients from Turkey: novel mutations and phenotypes.来自土耳其的1a型和1b型糖原贮积病患者的临床、实验室及分子特征:新突变与表型
Eur J Pediatr. 2025 Aug 9;184(9):540. doi: 10.1007/s00431-025-06371-7.
2
Development of hepatocellular adenomas in a patient with glycogen storage disease Ia treated with growth hormone therapy.一名接受生长激素治疗的糖原贮积病Ia型患者发生肝细胞腺瘤。
JIMD Rep. 2023 Aug 18;64(5):303-311. doi: 10.1002/jmd2.12381. eCollection 2023 Sep.
3
Glycogen storage diseases: An update.

本文引用的文献

1
Effect of human growth hormone treatment for 1 to 7 years on growth of 100 children, with growth hormone deficiency, low birthweight, inherited smallness, Turner's syndrome, and other complaints.对100名患有生长激素缺乏症、低出生体重、遗传性身材矮小、特纳综合征及其他病症的儿童进行1至7年生长激素治疗的效果
Arch Dis Child. 1971 Dec;46(250):745-82. doi: 10.1136/adc.46.250.745.
2
The serum apolipoprotein profile of patients with glucose-6-phosphatase deficiency.葡萄糖-6-磷酸酶缺乏症患者的血清载脂蛋白谱。
Pediatr Res. 1985 Apr;19(4):380-4. doi: 10.1203/00006450-198519040-00013.
3
Hepatic adenomata in type Ia glycogen storage disease.
糖原贮积病:更新。
World J Gastroenterol. 2023 Jul 7;29(25):3932-3963. doi: 10.3748/wjg.v29.i25.3932.
4
Glycogen storage disease in two sisters: A case report.两姐妹的糖原贮积病:一例报告
Clin Case Rep. 2023 May 4;11(5):e7318. doi: 10.1002/ccr3.7318. eCollection 2023 May.
5
Prevalence and Complications of Glycogen Storage Disease in South Korea: A Nationwide Population-Based Study, 2007-2018.2007-2018 年韩国糖原贮积病的流行率和并发症:一项全国基于人群的研究。
Biomed Res Int. 2022 Jul 1;2022:2304494. doi: 10.1155/2022/2304494. eCollection 2022.
6
Evaluation of Glycogen Storage Patients: Report of Twelve Novel Variants and New Clinical Findings in a Turkish Population.糖原贮积症患者评估:土耳其人群中 12 种新变异和新临床发现的报告。
Genes (Basel). 2021 Dec 15;12(12):1987. doi: 10.3390/genes12121987.
7
Hyperuricemia in Children and Adolescents: Present Knowledge and Future Directions.儿童和青少年高尿酸血症:当前认知与未来方向
J Nutr Metab. 2019 May 2;2019:3480718. doi: 10.1155/2019/3480718. eCollection 2019.
8
Glycogen metabolism and glycogen storage disorders.糖原代谢与糖原贮积症
Ann Transl Med. 2018 Dec;6(24):474. doi: 10.21037/atm.2018.10.59.
9
Glucose-6-phosphatase deficiency.葡萄糖-6-磷酸酶缺乏症。
Orphanet J Rare Dis. 2011 May 20;6:27. doi: 10.1186/1750-1172-6-27.
10
Glycogen storage diseases: new perspectives.糖原贮积病:新观点
World J Gastroenterol. 2007 May 14;13(18):2541-53. doi: 10.3748/wjg.v13.i18.2541.
Ia型糖原贮积病中的肝腺瘤
Arch Pathol Lab Med. 1987 Feb;111(2):166-9.
4
Renal disease in type I glycogen storage disease.I型糖原贮积病中的肾脏疾病
N Engl J Med. 1988 Jan 7;318(1):7-11. doi: 10.1056/NEJM198801073180102.
5
Hyperfiltration and renal disease in glycogen storage disease, type I.I型糖原贮积病中的超滤过与肾脏疾病
Kidney Int. 1989 Jun;35(6):1345-50. doi: 10.1038/ki.1989.133.